Regeneron Pharmaceuticals, Inc.

Rockefeller Capital Management L.P. REGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

3/16/2026

Shares

27,053

Value ($000)

20,882

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	3/16/2026	20,882	0.0%	27,053	12/31/2025
2025 Q3	11/14/2025	14,531	0.0%	25,842	9/30/2025
2025 Q2	8/8/2025	15,551	0.0%	29,620	6/30/2025
2025 Q1	5/14/2025	42,880	0.1%	67,608	3/31/2025
2024 Q4	2/13/2025	67,505	0.2%	94,744	12/31/2024
2024 Q3	11/14/2024	103,021	0.3%	98,004	9/30/2024
2024 Q2	8/12/2024	104,152	0.3%	99,100	6/30/2024
2024 Q1	5/14/2024	100,774	0.3%	104,701	3/31/2024
2023 Q4	2/14/2024	92,757	0.3%	105,611	12/31/2023
2023 Q3	11/14/2023	85,597	0.3%	104,011	9/30/2023
2023 Q2	8/14/2023	56,543	0.2%	78,692	6/30/2023
2023 Q1	5/16/2023	62,001	0.3%	75,459	3/31/2023
2022 Q4	3/6/2023	54,461	0.3%	75,486	12/31/2022
2022 Q3	11/2/2022	55,735	0.3%	80,910	9/30/2022
2022 Q2	8/12/2022	48,323	0.3%	81,749	6/30/2022
2022 Q1	5/13/2022	64,011	0.3%	91,652	3/31/2022
2021 Q4	2/14/2022	54,411	0.3%	86,160	12/31/2021
2021 Q3	11/12/2021	52,850	0.3%	87,334	9/30/2021
2021 Q2	8/10/2021	105,981	0.6%	189,750	6/30/2021
2021 Q1	5/11/2021	60,206	0.4%	127,252	3/31/2021
2020 Q4	2/12/2021	52,474	0.4%	108,621	12/31/2020
2020 Q3	11/13/2020	58,539	0.5%	104,580	9/30/2020
2020 Q2	8/12/2020	82,196	0.9%	131,799	6/30/2020
2020 Q1	5/12/2020	65,680	0.9%	134,509	3/31/2020
2019 Q4	2/7/2020	58,272	0.7%	155,191	12/31/2019